These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24766455)

  • 1. Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges.
    Pereira HM; Sardela VF
    Subst Use Misuse; 2014 Jul; 49(9):1098-114. PubMed ID: 24766455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review.
    Strano Rossi S; Botrè F
    J Sports Sci; 2011 Mar; 29(5):471-6. PubMed ID: 21279865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.
    Kioukia-Fougia N; Fragkaki A; Kiousi P; Leontiou IP; Dimopoulou H; Tsivou M; Lyris E; Georgakopoulos C
    J Anal Toxicol; 2014; 38(1):16-23. PubMed ID: 24194481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis.
    Strano-Rossi S; Colamonici C; Botrè F
    Anal Chim Acta; 2008 Jan; 606(2):217-22. PubMed ID: 18082653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of legal and illegal stimulating agents in sports.
    Deventer K; Roels K; Delbeke FT; Van Eenoo P
    Anal Bioanal Chem; 2011 Aug; 401(2):421-32. PubMed ID: 21479548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N,N-dimethyl-2-phenylpropan-1-amine - new designer agent found in athlete urine and nutritional supplement.
    Kwiatkowska D; Wójtowicz M; Jarek A; Goebel C; Chajewska K; Turek-Lepa E; Pokrywka A; Kazlauskas R
    Drug Test Anal; 2015 Apr; 7(4):331-5. PubMed ID: 25355281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs and sport. Research findings and limitations.
    Clarkson PM; Thompson HS
    Sports Med; 1997 Dec; 24(6):366-84. PubMed ID: 9421862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration.
    Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A
    Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody urine assay for amphetamines, cocaine and cannabinoids: a pilot study of Mexican athletes.
    Padilla J; Eguíalis MC; Mendoza F; Santos VA; Ojeda P
    Proc West Pharmacol Soc; 2002; 45():191-2. PubMed ID: 12434578
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulants and doping in sport.
    Thevis M; Sigmund G; Geyer H; Schänzer W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):89-105, ix. PubMed ID: 20122452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.
    Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.